Similar articles

• The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.

  Torda TA, Foldes FF, Bailey RJ, Klonymus DH, Kuwabara S. Torda TA, et al. Anesthesiology. 1967 Nov-Dec;28(6):1010-9. doi: 10.1097/00000542-196711000-00012. Anesthesiology. 1967. PMID: 4383425 No abstract available.
• The potentiation of neuromuscular blocking agents by quinidine.

  Miller RD, Way WL, Katzung BG. Miller RD, et al. Anesthesiology. 1967 Nov-Dec;28(6):1036-41. doi: 10.1097/00000542-196711000-00016. Anesthesiology. 1967. PMID: 4383426 No abstract available.
• The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat.

  Katz RL, Eakins KE. Katz RL, et al. J Pharmacol Exp Ther. 1966 Nov;154(2):303-9. J Pharmacol Exp Ther. 1966. PMID: 5922992 No abstract available.
• Monitoring of neuromuscular function.

  Ali HH, Savarese JJ. Ali HH, et al. Anesthesiology. 1976 Aug;45(2):216-49. doi: 10.1097/00000542-197608000-00009. Anesthesiology. 1976. PMID: 180849 Review. No abstract available.
• Muscle relaxant drugs.

  Thompson MA. Thompson MA. Br J Hosp Med. 1980 Feb;23(2):153-4, 163-4, 167-8 passim. Br J Hosp Med. 1980. PMID: 6102875 Review. No abstract available.